Navigation Links
Two Colorado Surgeons Become Pioneers In Microsurgical DIEP Flap Breast Reconstruction
Date:11/6/2008

Dr Jeremy Z Williams and Dr Christopher G Williams, both with Park Meadows Cosmetic Surgery center based in Lone Tree, Colorado will be working with a local hospital to bring DIEP Flap breast reconstruction to Colorado patients.

Denver, CO (PRWEB) November 6, 2008 -- With over 260,000 people being diagnosed with breast cancer every year, new alternatives to breast reconstruction are in constant demand. Dr Jeremy Z Williams and Dr Christopher G Williams, both with Park Meadows Cosmetic Surgery center based in Lone Tree, Colorado are bringing one of the newest and most exciting procedures to their clients, DIEP Flap breast reconstruction.

"Our goal with any surgical procedure is to provide maximum effectiveness to our patients," stated Dr Jeremy Williams. "As women recover, we want to help get them back to their normal lifestyle as quick as possible."

In the past, there have been few options available to women desiring breast reconstruction. Women could choose to have saline or silicone implants, use her own tissue flap, or a combination of the two. The transverse rectus abdominis muscle flap, or TRAM flap, was the most common of the procedures. The TRAM flap is the process of taking tissue and muscle from the abdominal area, and reconnecting it to form a breast shape. While the TRAM flap does offer women the opportunity to resume a natural look and feel, it does have drawbacks. Because the TRAM flap removes both tissue and muscle, some women may experience decreased strength in the abdominal area, making mobility difficult.

A newer procedure, the DIEP Flap (Deep Inferior Epigastric Perforator Flap), offers women a better choice.

DIEP Flap provides state of the art technology to
'/>"/>

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Colorado Medical School Receives Provisional Accreditation
2. Partnership for a Drug-Free America and Colorado Springs Police Department Introduce Methamphetamine Prevention Program to Colorado Law Enforcement
3. Angel Flight West Recognizes Colorado Pilots and Supporters at AFW 24th Anniversary Awards
4. Colorado Doctors of Chiropractic Win Awards
5. Golden Doctor of Chiropractic Elected President of the Colorado Chiropractic Association
6. Announcing Always Best Care Senior Services Expansion Into the Littleton/Denver, Colorado Area
7. Announcing Always Best Care Senior Services Expansion into Colorado Springs, Colorado
8. Colorado Influenza and Pneumococcal Alert Coalition (CIPAC) Partners with Novartis Vaccines for Holiday Vaccination Clinic, Making Influenza Vaccination Convenient for Shoppers
9. Colorado Casinos Clear the Air and Become Smoke-Free in 2008
10. American Life League Praises Colorado Efforts to Stop Planned Parenthood Abortion Facility
11. JDRF to establish an autoimmunity center at University of Colorado Denver

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Two Colorado Surgeons Become Pioneers In Microsurgical DIEP Flap Breast Reconstruction
Two Colorado Surgeons Become Pioneers In Microsurgical DIEP Flap Breast Reconstruction
(Date:11/25/2009)...RNewswire/--TheBartleHallConventionCenterwilltempo...-10,whenKansasCityhoststhelatestinaseriesofmassive...iceventhasthepotentialtobethebiggestoneyet,because...weekdaysinsteadofoveraweekend,"SheriWood,executive...toftheNationalAssociationofFreeClinics(NAFC). ,...
(Date:11/25/2009)...re/-SentinelleMedicalInc.,aleadingmanufacturerofbr...esasuiteofnewleadingedgeclinicalapplicationsonitsA...RadiologicalSocietyofNorthAmerica(RSNA)annualmeeti...applicationsleveragetheuniquehighqualityimagesgene...pportmultipleimagingmodalitiesformulti-parametrica...
(Date:11/25/2009)...swire-USNewswire/--TheBlackAIDSInstituterecentlyhe...ershipfor2010. ,, ThenewBoardMembersareahighlyd...law,finance,governmenthealthprograms,editorial,and...erangeofpersonalbackgroundsincludingbothheterosexu...es,andrepresentingmultipleagegroups. ,, (Photo:...
(Date:11/25/2009)...ular cancer who were treated with cisplatin-based ...ng neurological side effects and Raynaud-like phen...rapy, according to a new study published online No...nstitute . , Marianne Brydy, M.D., of the Depart...n Bergen, Norway, and colleagues conducted a cross...
(Date:11/25/2009)...essure? This simple question has been the focus o...ated gene Modulates High Blood Pressure in Mice & ...imple question has been the focus of intense resea...first time established a link between a novel gene...ress in mice as well as humans. The studies were d...
Breaking Medicine News(10 mins):Health News:Kansas City Prepares for Largest Free Health Clinic 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:Black AIDS Institute Announces 2010 Board Election Results 2Health News:New stress-related gene modulates high blood pressure in mice and men 2
... at reducing problems in heart transplant patients...y the drug reduced the incidence of a serious diso...wn as coronary vasculopathy.// Previous studi... University in Philadelphia conducted a study to d...
...nerable to serious brain injuries when they fall t...tigators distinguish between accidental and intent...a study found that rotational forces generated by ...issue and alter brain function, and nerve cell dam...
...ly common procedure for hard-to-treat cancers. The...take months or even years for stem cells// to beco...is at risk for serious infection. Now, researchers...experimental treatment. In Ed Bauters case...
...t sperm as they get older //and they found to thei...perm an edge. The deformed sperm increase the r...less are likely to beat out their healthy counterp...e is more common in children born to older fathers...
...thma attacks be causing the very thing it aims to ... School of Public Health and Brigham and Women’s H...wn as beta-agonists in asthmatics. Beta-ago...pill or liquid form, delivered in a nebulizer, or ...
...ath rate from it is falling due to early detection...versity of Southern Denmark carried out an analysi...ween 1993 and 1999. While the proportion of pe...Commenting on the findings published in this week'...
Other Medicine News:
(Date:11/25/2009)...inker.comannouncesthatanewmarketresearchreportisav...ry-USMarketTrends&Analysis http://www.reportl...arket-Trends--Analysis.html ,, TheUSintranasal...uticapplicationsfromthedeliveryofconventionallocal...drugs.Thefutureofthetechnologyhingesontotheeffecti...
(Date:11/25/2009)...re/-- ChemoCentryx,Inc.,announcedtodaythatPhaseII...ectiveRandomizedOralTherapyEvaluationinCrohn,sdise...moderate-to-severeCrohn,sdiseasedemonstratedclinic...le.Thestudydemonstratedevidenceofclinicalefficacyi...decreaseintheCrohn,sDiseaseActivityIndex(CDAI)inpa...
(Date:11/24/2009)...stCall/--Endologix,Inc.(Nasdaq: ELGX ),developerof...uncedtodaythatithasfiledamotiontostay,ordiscontinu...ghtagainstitinOctober2009byCook,Inc.Themotionwasfi...diana. ,, Endologixhasrequestedthatthestayremai...ice(USPTO)conductsproceedingstore-examinethetwopat...
Breaking Medicine Technology:Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement 2Sleep Management Device Unit Sales to Grow at a Compound Annual Growth Rate of Over 16 25 as CMS Reimbursement Expands 6280 1Sleep Management Device Unit Sales to Grow at a Compound Annual Growth Rate of Over 16 25 as CMS Reimbursement Expands 6280 2Sleep Management Device Unit Sales to Grow at a Compound Annual Growth Rate of Over 16 25 as CMS Reimbursement Expands 6280 3National Expressions of Courage Art Contest Unveils Stories of Inspiration 6277 1National Expressions of Courage Art Contest Unveils Stories of Inspiration 6277 2National Expressions of Courage Art Contest Unveils Stories of Inspiration 6277 3National Expressions of Courage Art Contest Unveils Stories of Inspiration 6277 4National Expressions of Courage Art Contest Unveils Stories of Inspiration 6277 5Lotus Pharmaceuticals Inc Reports Third Quarter 2009 Results 6274 1Lotus Pharmaceuticals Inc Reports Third Quarter 2009 Results 6274 2Lotus Pharmaceuticals Inc Reports Third Quarter 2009 Results 6274 3Lotus Pharmaceuticals Inc Reports Third Quarter 2009 Results 6274 4Lotus Pharmaceuticals Inc Reports Third Quarter 2009 Results 6274 5Lotus Pharmaceuticals Inc Reports Third Quarter 2009 Results 6274 6Lotus Pharmaceuticals Inc Reports Third Quarter 2009 Results 6274 7Lotus Pharmaceuticals Inc Reports Third Quarter 2009 Results 6274 8Lotus Pharmaceuticals Inc Reports Third Quarter 2009 Results 6274 9Lotus Pharmaceuticals Inc Reports Third Quarter 2009 Results 6274 10
...linical program to evaluate PROMUS(TM) Element(TM)...3 Boston Scientific Corporation (NYSE: BSX ) to...in the PLATINUM clinical trial, which is designed ...verolimus-Eluting Coronary Stent. The first U.S. ...er of the Rockies in Loveland, Colorado by Thomas ...
...NG-WEIHENSTEPHAN, Germany, February 3 Pieris AG, ...R), a novel class of targeted,human protein therap...,progress in the development of its Anticalin(R) c...oad therapeutic applicability. , Having succes...in vitro,and in vivo, Pieris has now validated the...
Other Medicine Technology:Boston Scientific Begins Clinical Trial Enrollment for New Everolimus-Eluting Stent 2Boston Scientific Begins Clinical Trial Enrollment for New Everolimus-Eluting Stent 3Boston Scientific Begins Clinical Trial Enrollment for New Everolimus-Eluting Stent 4Boston Scientific Begins Clinical Trial Enrollment for New Everolimus-Eluting Stent 5Pieris Reports Development Progress for Anticalin(R) PRS-050, a Next Generation VEGF Antagonist 2Pieris Reports Development Progress for Anticalin(R) PRS-050, a Next Generation VEGF Antagonist 3
Alkaline Phosphatase
Uric Acid (Uricase) (Single Reagent)
Uric acid FS TBHBA
Uric Acid
Medicine Products: